<DOC>
	<DOCNO>NCT01811823</DOCNO>
	<brief_summary>Prospective , open-labelled study enrol 360 participant four group 80 participant include : HIV-uninfected adult without evidence TB ; HIV-infected adult without evidence TB ; HIV-uninfected adult concurrent microbiologic confirm TB , HIV-infected adult concurrent microbiologic confirm TB . Participants receive recommend seasonal 2013 un-adjuvanted Trivalent Influenza Vaccine ( TIV ) . At 3 visit , blood collect determination immune response . Objective : • To determine effect HIV-infection , tuberculosis ( TB ) HIV-TB co-infection immune response</brief_summary>
	<brief_title>Effect HIV and/or Active Tuberculosis Immune Responses Trivalent Influenza Vaccine ( TIV ) Adults</brief_title>
	<detailed_description />
	<mesh_term>Influenza , Human</mesh_term>
	<mesh_term>Tuberculosis</mesh_term>
	<mesh_term>Vaccines</mesh_term>
	<criteria>HIVinfected subject : Cluster Differntiation4 ( CD4+ ) cell count &gt; 100/ul within previous 3 month ; able attend clinic immunogenicity illness visit ; subject TB : microbiologic confirm diagnosis TB ( define presence acidfastbacilli ( AFB ) sputum smear specimen and/or positive culture M. tuberculosis ) within past 120 day ; Aged 18 55 year . contraindication influenza vaccine ; contraindication intramuscular injection ; exist grade 3 grade 4 laboratory clinical toxicity per Division Acquired Immune Deficiency Syndrome ( DAIDS ) toxicity table ; systemic steroid treatment &gt; 21 day within past 30 day . pregnancy ( urine Human Chorionic Gonadotropin ( βHCG ) perform woman childbearing age exclude pregnancy )</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>August 2014</verification_date>
	<keyword>Tuberculosis</keyword>
	<keyword>HIV infection</keyword>
	<keyword>Immune responses Influenza vaccination</keyword>
</DOC>